Mid-Day Market Update: Dow Surges Over 200 Points; AquaBounty Technologies Shares Plummet
|Midway through trading Friday, the Dow traded up 0.79 percent to 25,776.71 while the NASDAQ climbed 0.57 percent to 7,252.69. The S&P also rose, gaining 0.49 percent to 2,781.24
.
Leading and Lagging Sectors
On Friday, the technology sector proved to be a source of strength for the market. Leading the sector was strength from Synaptics, Incorporated SYNA 13.33% and Motorola Solutions Inc MSI 3.53%.
In trading on Friday, utilities shares rose by just 0.1 percent. Meanwhile, top losers in the sector included American Water Works Company Inc AWK 4.44%, down 3 percent, and Aqua America Inc WTR 3% down 2 percent.
Top Headline
JPMorgan Chase & Co. JPM 1.02% reported better-than-expected earnings for its fourth quarter.
JPMorgan said it earned $1.76 per share in the quarter on revenue of $25.45 billion which exceeded Wall Street's expectations for $1.69 per share and $25.15 billion.
Equities Trading UP
SAExploration Holdings, Inc. SAEX 9.76% shares shot up 15 percent to $2.78 after the company disclosed that it has received around $15.7 million of additional Alaskan tax credit certificates.
Shares of Liberty Oilfield Services Inc. LBRT got a boost, shooting up 28 percent to $21.70. Liberty Oilfield Services priced its 12.7 million share IPO at $17 per share.
Tuniu Corp TOUR 11.7% shares were also up, gaining 12 percent to $8.54. Tuniu reported a $100 million share repurchase program and reported the promotion of Mr. Shihong Chen from Vice President to Chief Technology Officer, effective immediately.
Equities Trading DOWN
Aradigm Corporation ARDM 33.52% shares dropped 36 percent to $2.19 after the company disclosed that the FDA Advisory Committee panel voted 12-3 against recommendation for Linhaliq. Ladenburg Thalmann downgraded Aradigm from Buy to Neutral.
Shares of AquaBounty Technologies, Inc. AQB 38.27% were down 38 percent to $3.03 after the company reported a $12 million underwritten public offering.
Concert Pharmaceuticals Inc CNCE 27.35% was down, falling around 25 percent to $20.65. Concert Pharmaceuticals disclosed that it has been granted Fast Track designation for CTP-543 for the treatment of alopecia areat. The company also reported that the Patent Trial and Appeal Board of the U.S. Patent and Trademark Office did not institute PGR proceeding.
Commodities
In commodity news, oil traded down 0.42 percent to $63.53 while gold traded up 0.64 percent to $1,330.90.
Silver traded up 1 percent Friday to $17.135, while copper fell 0.23 percent to $3.2255.
Eurozone
European shares were higher today. The eurozone’s STOXX 600 gained 0.28 percent, the Spanish Ibex Index rose 0.28 percent, while Italy’s FTSE MIB Index rose 0.62 percent. Meanwhile the German DAX climbed 0.19 percent, and the French CAC 40 rose 0.38 percent while U.K. shares rose 0.35 percent.
Economics
U.S. retail sales rose 0.4 percent for December, versus economists’ expectations for a 0.4 percent growth.
The consumer price index gained 0.1 percent in December, versus economists’ expectations for a 0.1 percent rise.
U.S. business inventories gained 0.4 percent for November, versus economists’ estimates of a 0.3 percent growth
The Baker Hughes North American rig count report for the latest week is schedule for release at 1:00 p.m. ET.
Boston Federal Reserve Bank President Eric Rosengren will speak in La Jolla, California at 4:15 p.m. ET.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.